Namuscla European Union - English - EMA (European Medicines Agency)

namuscla

lupin europe gmbh - mexiletine hydrochloride - myotonic disorders - cardiac therapy - namuscla is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders.